By Matt Riesenbach, Director of Product Management, ECI Software Solutions

Understanding the Impact of GLP-1 Medications on Food Manufacturing

Key Takeaways:

• The rise of GLP-1 medications is transforming consumer eating habits, leading to significant fluctuations in the food market, particularly in snacks, baked goods, and beverages.
• Small and mid-sized businesses (SMBs) are experiencing reformulation pressures similar to large consumer packaged goods (CPG) companies but lack the same resources, putting their competitive edge at risk.
• A modern ERP system is crucial for SMBs to adapt quickly, manage product reformulations, and plan scenarios effectively.

In a climate marked by inflation, labor shortages, and supply chain disruptions, the food industry is undergoing a significant transformation. The latest drivers of change are GLP-1 medications, which are reshaping consumer behaviors in ways not seen for decades. These changes are much more than mere ingredient swaps; they affect appetite, meal frequency, snacking habits, macronutrient choices, and overall category demand.

The adoption of GLP-1 medications is anticipated to surge through 2026, further complicating the landscape for food manufacturers. In the past year alone, new prescriptions for GLP-1s increased by 2.9 million, marking a 16% year-over-year growth. Early insights reveal that consumers utilizing these medications are choosing smaller portion sizes, favoring protein-rich and fiber-enriched foods, decreasing snacking frequency, and critically analyzing calorie density. Categories such as prepared meals, snack bars, granola, baked goods, and beverages are experiencing notable volatility as a result.

Challenges Faced by SMBs

As market dynamics evolve, speed of response often hinges on resource availability. Unlike large CPG companies, which have dedicated teams for nutrition science and reformulation processes, SMBs usually rely on limited product development teams and outdated tools that can hinder their agility. This discrepancy creates substantial operational challenges:

For instance, formulation changes require revalidation due to inconsistent data sources, and packaging updates can take weeks or months to achieve. The need to meet consumer demands for rapid reformulation underscores this need for enhanced agility.

Nevertheless, there is an upside for SMBs. Companies that proactively manage their ingredient, formula, nutrition, and packaging data can outpace competitors dependent on outdated methods.

Leveraging ERP Systems for Agility

In an environment where consumer preferences are fluid, ERP systems are becoming essential for manufacturing agility. They serve a critical role by centralizing the data necessary for making timely changes. A modern ERP provides a unified platform for ingredient information, recipes, yields, allergens, and specifications, enabling manufacturers to efficiently adapt. This capability allows for comprehensive portfolio assessments tailored to GLP-1 consumer trends.

How SMBs Can Differentiate Themselves:

• Fast Reformulation: With GLP-1 influenced shifts in consumer habits, companies must assess core recipes swiftly. The ability to test multiple versions while maintaining accurate information is vital, and a strong data governance within ERP can streamline this process.
• Label and Packaging Adjustments: Reformulating products often leads to label changes, necessitating accurate data management and effective communication among R&D, QA, and packaging teams to mitigate compliance risks.
• Demand and Portfolio Planning: Understanding which SKUs warrant reformulation is crucial. An ERP equipped with planning and costing tools can give manufacturers the insights needed to approach resource commitments wisely.

Moving Forward with Confidence

The influence of GLP-1 medications is likely a lasting transformation rather than a fleeting trend. Manufacturers who successfully blend innovation with operational agility will surpass those relying on outdated manual processes.

To navigate these changes effectively, manufacturers must enhance their master data governance, streamline workflows for low-risk updates, improve inter-departmental coordination, and expand their scenario planning capabilities. Implementing these strategies will equip companies to respond to GLP-1 shifts with clarity and efficiency, minimizing guesswork.

Matt Riesenbach is the Product Management Director at ECI Software Solutions, a provider of cloud-based business management software for manufacturers. He has nearly a decade of experience with ECI Software Solutions and its Deacom ERP Software for batch and process manufacturers.